Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Strong

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|March 16, 1983
Fast atom bombardment: evidence of disproportionation and recombination of a synthetic porphyrin in the matrixL Kurlansik, T J Williams, J E Campana, et al.
Clinical Pharmacology and Therapeutics|February 11, 1975
Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidideJ M Strong, D E Mayfield, A J Atkinson, et al.
European Journal of Biochemistry|November 15, 1992
Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivoD W Zaharevitz, L W Anderson, N M Malinowski, et al.
Clinical Pharmacology and Therapeutics|July 1, 1985
Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulationR W Klecker, J F Jenkins, T J Kinsella, et al.
The American Journal of Physiology|January 22, 1998
Determination of cerebral glucose transport and metabolic kinetics by dynamic MR spectroscopyP C Van Zijl, D Davis, S M Eleff, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1997
In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slicesP J McNeilly, C D Torchin, L W Anderson, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedineS O'Reilly, N R Hartman, K M Bowling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapyL W Anderson, T L Chen, O M Colvin, et al.
Journal of Chromatography. B, Biomedical Applications|April 22, 1994
Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatographyC H Takimoto, R W Klecker, W L Dahut, et al.
Cancer Research|March 1, 1997
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedineW R Waud, A Tiwari, S M Schmid, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|March 16, 1983
Fast atom bombardment: evidence of disproportionation and recombination of a synthetic porphyrin in the matrixL Kurlansik, T J Williams, J E Campana, et al.
Clinical Pharmacology and Therapeutics|February 11, 1975
Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidideJ M Strong, D E Mayfield, A J Atkinson, et al.
European Journal of Biochemistry|November 15, 1992
Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivoD W Zaharevitz, L W Anderson, N M Malinowski, et al.
Clinical Pharmacology and Therapeutics|July 1, 1985
Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulationR W Klecker, J F Jenkins, T J Kinsella, et al.
The American Journal of Physiology|January 22, 1998
Determination of cerebral glucose transport and metabolic kinetics by dynamic MR spectroscopyP C Van Zijl, D Davis, S M Eleff, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1997
In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slicesP J McNeilly, C D Torchin, L W Anderson, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedineS O'Reilly, N R Hartman, K M Bowling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapyL W Anderson, T L Chen, O M Colvin, et al.
Journal of Chromatography. B, Biomedical Applications|April 22, 1994
Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatographyC H Takimoto, R W Klecker, W L Dahut, et al.
Cancer Research|March 1, 1997
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedineW R Waud, A Tiwari, S M Schmid, et al.
Pageof 8